Found 22 matching trials
A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants PHASE3 The main aim of the study is to check side effect from the study treatment ...
Show More Location
Nagoya University Hospital
Learn More & Join Trial
A Study of TAK-881 and HyQvia in Healthy Adults PHASE1 The main aim of this study is to understand how the body absorbs, processes...
Show More Learn More & Join Trial
A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) PHASE3 The main aim of the study is to check for side effects from TAK-771, and to...
Show More Location
Aichi Medical University Hospital
Learn More & Join Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) N/A The purpose of the proposed study is to acquire additional data (including ...
Show More Location
Kern Allergy Medical Clinic
Learn More & Join Trial
Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously PHASE1 The purpose of the study is to determine the feasibility of infusing a full...
Show More Location
First Allergy and Clinical Research Center
Learn More & Join Trial
A Study of TAK-881 in Healthy Adults PHASE1 The main aims of this study are to check for side effects from TAK-881 in h...
Show More Location
Clinical Pharmacology of Miami
Learn More & Join Trial
A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants PHASE1 The purpose of the study is to assess the tolerability, safety, and pharmac...
Show More Location
Clinical Pharmacology of Miami, Inc
Learn More & Join Trial
Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID PHASE3 The original purpose of the study is to assess the long-term safety, tolera...
Show More Location
Multiple Locations
Learn More & Join Trial
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD PHASE2 The purpose of the study is to acquire additional data on safety and tolera...
Show More Location
University of California, Irvine
Learn More & Join Trial
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases PHASE3 The main aim of this study is to learn if TAK-881 is safe and well tolerate...
Show More Status
Active Not Recruiting
Location
University of California, Irvine Medical Sciences I
Learn More & Join Trial